Trial Profile
A 24-week, randomized, parallel study evaluating efficacy of testosterone replacement therapy (TRT) on concomitant dutasteride in men with late-onset hypogonadism.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 04 Jul 2016
Price :
$35
*
At a glance
- Drugs Dutasteride (Primary) ; Testosterone (Primary)
- Indications Hypogonadism
- Focus Therapeutic Use
- 04 Jul 2016 New trial record